Martin Whitaker
non-executive director
pharmaceutical sciences
ph Pharma co
Netherlands
Biography
Martin Whitaker is a non-executive director at PH Therapeutics a spin-out company from the University of Sheffield where he is a Business Manager for Fusion IP PLC. Martin is currently Chief Executive Officer of the Fusion IP company, Diurnal, with overall responsibility for delivering the company’s commercial objectives and has over 10 years’ experience in the pharmaceutical industry. Martin is also Director of Faveo Limited commercialising intellectual property in the apparel field. Prior to this Martin was Operations Director of Critical Pharmaceuticals Limited, a venture capital backed drug delivery company spun out of the University of Nottingham. Martin had overall responsibility for product development, building and developing the scientific team as well being part of the fund raising team that secured £3M in funding over a four year period. Martin is a biochemist by background and has a PhD in Pharmaceutical Science from the University of Nottingham. Martin also spent a year working for Pfizer in the Pharmaceutical R&D Department at Pfizer Global R&D (UK).
Research Interest
